Mood stabilizing drug lithium increases expression of endoplasmic reticulum stress proteins in primary cultured rat cerebral cortical cells
about
Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorderThe role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesisEndoplasmic Reticulum Stress and Associated ROSRedox Modulations, Antioxidants, and Neuropsychiatric DisordersXenobiotic perturbation of ER stress and the unfolded protein responseCell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunitiesEndoplasmic reticulum stress and unfolded protein response in renal pathophysiology: Janus facesChondrocyte-specific pathology during skeletal growth and therapeutics in a murine model of pseudoachondroplasiaMultiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: developing treatments using an integrated translational approachProtein Disulfide Isomerase Superfamily in Disease and the Regulation of ApoptosisLithium induces ER stress and N-glycan modification in galactose-grown Jurkat cells.Bax inhibitor 1, a modulator of calcium homeostasis, confers affective resilience.Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disordersA review of the mammalian unfolded protein response.Decreased gene expression activity as a result of a mutation in the calreticulin gene promoter in a family case of schizoaffective disorder.Defects of mitochondrial electron transport chain in bipolar disorder: implications for mood-stabilizing treatment.Endoplasmic reticulum stress: its role in disease and novel prospects for therapy.Targeting histone deacetylases for the treatment of diseaseTranslating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder.Effect of chronic valproic Acid treatment on hepatic gene expression profile in wfs1 knockout mouse.Emerging drugs for amyotrophic lateral sclerosis.Epigenetic treatment of neurological disease.Targeting Huntington's disease through histone deacetylases.Challenges in drug target discovery in bipolar disorder.The unfolded protein response triggered by environmental factors.Chronic neuroprotective effects of low concentration lithium on SH-SY5Y cells: possible involvement of stress proteins and gene expression.Impaired endoplasmic reticulum stress response in bipolar disorder: cellular evidence of illness progression.Aberrant endoplasmic reticulum stress response in lymphoblastoid cells from patients with bipolar disorder.Functional Consequences of CHRNA7 Copy-Number Alterations in Induced Pluripotent Stem Cells and Neural Progenitor Cells.4-Phenylbutyric Acid (4-PBA) and Lithium Cooperatively Attenuate Cell Death during Oxygen-Glucose Deprivation (OGD) and Reoxygenation.Autophagy regulates endoplasmic reticulum stress in ischemic preconditioning.The Relationship between the Number of Manic Episodes and Oxidative Stress Indicators in Bipolar Disorder.
P2860
Q24626017-16ABCB3F-304B-4216-9FDB-295B3FEBCC2AQ24651407-2D1DE7AB-4A7F-4AC5-898A-6E70847E09F2Q26767386-36434812-4986-4769-9DF0-9186E76596A6Q26774067-0EC3E3DA-5A32-4649-BE05-49B6B1E06E95Q26998690-970DD9F4-AC6C-486B-A00F-4815D2472642Q29617768-6DC868BB-F72F-47EF-B53B-C68E0238201FQ30039723-68130DEF-CAB7-4DC6-8506-C49C5369F919Q33821143-D71CD797-8739-4688-9448-211322B32321Q34268501-E32DB469-9DFC-40F9-9A6F-1F78834151D4Q34318367-0C99317A-2E36-4108-B0EA-3DD79C333198Q34876367-1FC8C91D-2B10-436A-BAE3-BFAA9943E648Q35098811-F9D02B76-B3D0-458D-8E07-7BC316362831Q35197096-625CE0DF-9A4D-4E7B-8A78-3A2BE716D0DBQ35354864-F8666CEC-FE09-4934-95D7-585F55F7FA3AQ36910064-50AD7C19-22BC-4043-964B-EAB725653E3BQ37054253-ADB91051-8D62-49B3-9CA3-ED2E58F78CD0Q37288073-A55CC609-7145-4D05-B7EE-AB3E33A6D559Q37296159-5EE40EE8-AA12-45DB-A519-0F408A7F2DD4Q37607009-9E0E055C-047C-42CE-A724-D8AD5D39F28BQ37715873-1C805CE7-3190-43EC-97A9-80ED390A586DQ37909351-B3875CDA-462F-48DD-8DC3-91F9F91FE7C7Q37962584-E5DAEF78-C390-4D10-8C94-1EEA044085CDQ38019159-BCADF830-1DFD-4437-ACA3-3576A37112BAQ38082552-F3BDD9AF-C698-445D-A11D-1E3964BF8645Q38095787-869547C5-EE7D-413D-AC4B-C719B77E17EFQ38248009-2BFED169-00A8-4B30-90B3-3447AE6920F8Q39264714-A8F3DE12-4057-4CAB-8799-33EC0641AD4DQ42441252-9C07C71F-FC84-450D-940B-F51DAC8C2C92Q45874331-077AE2FB-0E66-40A7-8876-573116EB05BDQ48278176-838C64D7-EEC8-44BD-93DA-2C731C71BAC9Q48643764-491C78FD-5D36-4B2C-B5E2-51C25B178E2BQ52315028-348FC705-F441-45A8-924E-DEE62CAFCC1A
P2860
Mood stabilizing drug lithium increases expression of endoplasmic reticulum stress proteins in primary cultured rat cerebral cortical cells
description
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2006
@ast
im Februar 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2006/02/16)
@sk
vědecký článek publikovaný v roce 2006
@cs
wetenschappelijk artikel (gepubliceerd op 2006/02/16)
@nl
наукова стаття, опублікована в лютому 2006
@uk
مقالة علمية (نشرت في 16-2-2006)
@ar
name
Mood stabilizing drug lithium ...... ed rat cerebral cortical cells
@ast
Mood stabilizing drug lithium ...... ed rat cerebral cortical cells
@en
Mood stabilizing drug lithium ...... ed rat cerebral cortical cells
@nl
type
label
Mood stabilizing drug lithium ...... ed rat cerebral cortical cells
@ast
Mood stabilizing drug lithium ...... ed rat cerebral cortical cells
@en
Mood stabilizing drug lithium ...... ed rat cerebral cortical cells
@nl
prefLabel
Mood stabilizing drug lithium ...... ed rat cerebral cortical cells
@ast
Mood stabilizing drug lithium ...... ed rat cerebral cortical cells
@en
Mood stabilizing drug lithium ...... ed rat cerebral cortical cells
@nl
P2093
P1433
P1476
Mood stabilizing drug lithium ...... ed rat cerebral cortical cells
@en
P2093
P304
P356
10.1016/J.LFS.2005.07.007
P407
P577
2005-10-19T00:00:00Z